Amy Hakim, M.D., M.S.
Gynecologic Oncologist
4.7 (112 RATINGS)
Clinical Expertise
Gynecologic Oncology Surgery
Research Area
Gynecologic Oncology
Appointments
Assistant Clinical Professor, Division of Gynecologic Oncology, Department of Surgery
Clinical Teams
Amy Hakim, M.D., is a surgical oncologist dedicated to treating gynecological cancers. Dr. Hakim also studies the connection between these cancers’ and human papillomavirus (HPV) and the HPV vaccine. She has authored multiple papers on this topic.
Dr. Hakim received her medical degree at the University of Minnesota Medical School in Minneapolis and completed her OB/GYN fellowship at University of Hawaii’s John A. Burns School of Medicine. She then underwent additional OB/GYN fellowship training at Northwestern University’s Feinberg School of Medicine in Chicago, City of Hope and University of Texas Medical Branch-Methodist Hospital in Galveston and Houston.
California State Medical License
2001, University of Minnesota Medical School, Minneapolis, MN, awarded M.D.
1997, University of Virginia, Charlottesville, Virginia, Master of Science, Epidemiology
1993, University of Virginia, Charlottesville, Virginia, Master of Arts, Economics
1987, Carlton College, Northfield, Minnesota, Bachelor of Arts, Economics
2008-2010, Gynecologic Oncology Fellow, University of Texas Medical Branch-Methodist Hospital, Galveston and Houston, TX
2007-2008, Gynecologic Oncology Fellow, City of Hope, Duarte, CA
2005-2007, Gynecologic Oncology Fellow, Northwestern University Feinberg School of Medicine, Chicago, IL
2001-2005, Obstetrics and Gynecology Resident, John A. Burns School of Medicine, Honolulu, HI
Candidate Member of the Society of Gynecologic Oncologists
- Cristea MC, Frankel P, Synold T, Rivkin S, Lim D, Chung V, Chao J, Wakabayashi M, Paz B, Han E, Lin P, Leong L, Hakim A, Carroll M, Prakash N, Dellinger TH, Park M, Morgan RJ. A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Cancer Chemother Pharmacol. 2019 Jan 8. doi: 10.1007/s00280-019-03767-9. PMID: 30623229
- Cristea MC, Frankel P, Synold T, Rivkin S, Lim D, Chung V, Chao J, Wakabayashi M, Paz B, Han E, Lin P, Leong L, Hakim A, Carroll A, Openshaw H, Prakash N, Dellinger T, Park M, Morgan RJ. A Phase I trial of intraperitoneal nab-Paclitaxel (Abraxane®) in the treatment of advanced malignancies primarily confined to the peritoneal cavity". Cancer and Pharmacology. 83 (2019) 589-598. PMID: 30623229
- Dellinger TH, Hakim A, S. Lee S, Wakabayashi M, Morgan RM, Han ES. Surgical management of vulvar cancer. J Natl Compr Canc Netw. 2017 Jan;15(1):121-128. PMID: 28040722
- Otis-Green S, Wakabayashi MT, Morgan R, Hakim A, Ferrell B, Sun V, Yang E, Grant MJ. Palliative Care Opportunities for Women with Advanced Ovarian Cancer Associated with Intraperitoneal Chemotherapy. J Palliative Med. 2013 Jan; 16(1);44-53, doi: 10. 1089/jpm.2012.0174. Epub 2012 Dec 28. PMID: 23272673
- Sun V, Otis-Green S, Morgan R, Wakabayashi M, Hakim, A, Callado ME; Yang E, Ferrell B, Grant M. Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer., European Journal of Oncology Nursing;e: 17 (2013), pp. 375-380 DOI information 10.1016/j. ejon.2012.10.005. PMID: 23153453
- Hakim AA, Dinh TA. Worldwide Impact of the Human Papillomavirus Vaccine. Curr Treat Options Oncol. 2009 April 23 [Epub ahead of print].
- Hakim AA, Barry CP, Barnes HJ, Anderson KE, Petitte J, Whitaker R, Lancaster JM, Wenham RM, Carver DK, Turbov J, Berchuck A, Kopelvich L, Rodriguez GC. Ovarian adenocarcinomas in the Laying Hen and Women Share Similar Alterations in p53, ras, and HER-2/neu. Cancer Prev Res (Phil Pa). 2009 Feb;2(2):114-21.
- Wakabayashi MT, Lin PS, Hakim AA. The Role of Cytoreductive/Debulking Surgery in Ovarian Cancer. J Natl Compr Canc Netw. 2008 Sep;6(8):803-10.; quiz 811. Review.
- Hakim AA, Lin PS, Wilczynski S, Nguyen K, Lynes B, Wakabayashi MT. Indications and Efficacy of the Human Papilloma Vaccine. Current Treat Options in Oncol. 2007. Dec;8(6):393-401.
- Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Su E, Marsh E, Hakim A, Yin P, Ishikawa H, Amin S, Imir G, Gurantes B, Attar E, Reierstad S, Innes J, Lin Z. Aromatase Excess in Cancers of the Breast, Endometrium, and Ovary. J Steroid Biochem and Molec Biol. 2007. August-September;1061(1-5):81-96.
- Hakim AA, Terada K. Sentinel Node Dissection in Vulvar Cancer. Current Treat Options in Oncol. 2006;7:85-91.; Hakim AA, Curb JD, Burchfiel CM, Rodriguez BL, Sharp DS, Yano K, Abbott RD. Screening for Coronary Heart Disease in Elderly Men Based on Current and Past Cholesterol Levels: The Honolulu Heart Program. J Clin Epidemiol. 1999;52;1257-1265.
- Hakim AA, Curb JD, Petrovitch H, Rodriguez BL, Yano K, Ross GW, White LR, Abbott RD. Effects of Walking on Coronary Heart Disease in Elderly Men: The Honolulu Heart Program. Circulation. 1999;100:9-13.
- Abbott RD, Yano K, Hakim AA, Burchfiel CM, Sharp DS, Rodriguez BL, Curb JD. Expected Changes in Lipid and Lipoprotein Concentrations Over a Ten Year Period by Risk Factor Level and Prevalent Disease Status: The Honolulu Heart Program. American Journal of Cardiology. 1998;82:172-178.
- Hakim AA, Ross GW, Curb JD, Rodriguez BL, Burchfiel CM, Sharp DS, Yano K, Abbott RD. Coffee Consumption in Hypertensive Men in Older Middle-Age and the Risk of Stroke: The Honolulu Heart Program. J Clin Epidemiol 1998;51(6):487-494.
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Ratings
4.9
Spend enough time with you
4.8
Show respect for what you say
4.7
Rate provider 0-10
4.7
Provider explain in way you understand
4.7
Provider listen carefully to you
4.6
Know important info medical history
4.6
Recommend this provider office
Reviews
02/10/23
Love my doctor, very sensitive and supportive to how I was feeling. I could not stop bragging to friends and family about how good this doctor is one of the best I have met [...] - Verified patient
02/10/23
I already have recommended Dr Hakim and the City of Hope services. Very efficient organization, everything was taken care of by staff from help in filling out forms to setting appointments etc. Absolutely easy from patients' point of view while going through difficult medical issues - Verified patient
02/01/23
Dr. Hakim was awesome in all aspects. She was very detailed most professional very patient in listening and she made me feel more at ease in regards to my issue. - Verified patient
12/10/22
Dr. Hakim is a caring doctor that takes time with you and I would only see her for my yearly check up ! I just love her ! - Verified patient
10/31/22
Good listener and thorough . - Verified patient